Explore peer-reviewed research articles, clinical trials, and molecular pathways in inflammatory diseases
Discover how fluvoxamine, a common antidepressant, inhibits inflammatory gene expression through the NF-κB pathway, revealing its potential as an anti-inflammatory agent.